2020-04-24
A review of six Phase 3 studies shows that tofacitinib is more effective for rheumatoid arthritis (RA) treatment than regimens including placebo and a disease modifying anti-rheumatic drug or methotrexate (MTX) as monotherapy or in combination therapy. The efficacy of tofacitinib was similar in pati Read More